TB Group Inc. (TYO:6775)
Japan · Delayed Price · Currency is JPY 101.00
-1.00 (-0.98%)
Nov 12, 2026, 3:30 PM JST
TB Group Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 2,303 | 2,460 | 2,329 | 2,304 | 2,347 | 2,421 | |
Revenue Growth | -5.88% | 5.63% | 1.08% | -1.83% | -3.06% | -1.43% |
Cost of Revenue | 1,032 | 1,075 | 993 | 966 | 1,076 | 1,125 |
Gross Profit | 1,271 | 1,385 | 1,336 | 1,338 | 1,271 | 1,296 |
Selling, General & Admin | 1,436 | 1,450 | 1,514 | 1,542 | 1,519 | 1,560 |
Operating Expenses | 1,449 | 1,460 | 1,533 | 1,561 | 1,531 | 1,563 |
Operating Income | -178 | -75 | -197 | -223 | -260 | -267 |
Interest Expense | -11 | -11 | -6 | -3 | -3 | -2 |
Earnings From Equity Investments | - | 1 | 14 | 6 | 4 | -6 |
Currency Exchange Gain (Loss) | -2 | -4 | 3 | -8 | - | - |
Other Non Operating Income (Expenses) | 2 | 6 | 1 | -3 | 16 | 70 |
EBT Excluding Unusual Items | -189 | -83 | -185 | -231 | -243 | -205 |
Gain (Loss) on Sale of Investments | -5 | -108 | - | - | - | - |
Asset Writedown | -25 | -25 | - | -5 | - | - |
Other Unusual Items | 30 | 30 | 4 | - | 5 | - |
Pretax Income | -189 | -186 | -181 | -236 | -238 | -205 |
Income Tax Expense | 9 | 9 | 12 | 9 | 7 | 11 |
Earnings From Continuing Operations | -198 | -195 | -193 | -245 | -245 | -216 |
Minority Interest in Earnings | - | - | - | 1 | - | -1 |
Net Income | -198 | -195 | -193 | -244 | -245 | -217 |
Net Income to Common | -198 | -195 | -193 | -244 | -245 | -217 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 11 | 10 |
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 11 | 10 |
Shares Change | 3.27% | 1.65% | 0.15% | 27.76% | 7.65% | 5.95% |
EPS (Basic) | -13.94 | -14.03 | -14.11 | -17.86 | -22.92 | -21.85 |
EPS (Diluted) | -13.94 | -14.03 | -14.11 | -17.86 | -22.92 | -21.85 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | -211 | -7 | -252 | -294 | -316 | -299 |
Free Cash Flow Per Share | -14.86 | -0.50 | -18.42 | -21.53 | -29.56 | -30.11 |
Gross Margin | 55.19% | 56.30% | 57.36% | 58.07% | 54.15% | 53.53% |
Operating Margin | -7.73% | -3.05% | -8.46% | -9.68% | -11.08% | -11.03% |
Profit Margin | -8.60% | -7.93% | -8.29% | -10.59% | -10.44% | -8.96% |
Free Cash Flow Margin | -9.16% | -0.29% | -10.82% | -12.76% | -13.46% | -12.35% |
EBITDA | -158 | -54 | -167 | -182 | -223 | -226 |
EBITDA Margin | -6.86% | -2.20% | -7.17% | -7.90% | -9.50% | -9.34% |
D&A For EBITDA | 20 | 21 | 30 | 41 | 37 | 41 |
EBIT | -178 | -75 | -197 | -223 | -260 | -267 |
EBIT Margin | -7.73% | -3.05% | -8.46% | -9.68% | -11.08% | -11.03% |
Advertising Expenses | - | 5 | 5 | 6 | 5 | 2 |